USD/MDL - 17.96 ▲ 0
EUR/MDL - 20.07 ▲ 0
VMS_91 - 3.03%
VMS_364 - 9.54%
BONDS_2Y - 7.40%
SP500 - 735.29 ▲ 0.31%
GOLD - 4055.57 ▼ 0.31%
SILVER - 51.62 ▼ 0.6%
EURUSD - 1.12 ▲ 0%
BRENT - 123.93 ▲ 8.56%
GAS - 2.99 ▲ 1.36%
Advertisement

Switzerland will provide the Republic of Moldova with 5.6 million dollars to improve refugees’ access to healthcare

The Republic of Moldova will benefit from a US$5.6 million project, funded by Switzerland, aimed at improving access to healthcare for refugees and vulnerable migrants.
Svetlana Rudenco Svetlana Rudenco Reading time: 2 minutes
Text size
Link copied
medicines

The project will run for 30 months and aims to remove barriers to accessing healthcare services, improve patient navigation within the healthcare system, and expand access to mental health services and psychosocial support.

The initiative aims to support 6,000 vulnerable people, provide medical information and guidance services to 10,000 refugees and migrants, and ensure psychosocial support for 12,000 beneficiaries. At the same time, 200 frontline professionals and civil society representatives will receive training to respond more effectively to the needs of these groups.

“For a refugee mother, it matters greatly where she can secure medical support for her children, and patients who come, for example, to continue their treatment for diabetes or a cardiovascular condition need to know where they can obtain the medication required to continue their treatment,” said the Minister of Health, Alexandru Gasnaș.

The project targets refugees from Ukraine and other vulnerable foreign nationals in the Republic of Moldova, including those on both banks of the Dniester River. Implementation will focus on strengthening the national health system and the mechanisms for financing and reimbursing medical services, without creating parallel structures.

This story was translated with the assistance of artificial intelligence.The translation was also reviewed by the Logos Press editorial team.


How did this story make you feel?

Comments

0

No comments yet. You can start the conversation.

Comments are open to readers with a Logos Press account.

Sign in to comment

Related*
More from author*

We always appreciate your feedback!

Latest news
Popular now*
Must Read*